This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
TVEC has only been approved for the treatment of superficial melanoma metastases. All treated tumours at least became smaller, and no tumour grew further under the therapy. In addition to the clinical studies, the researchers from the Department of Dermatology, in cooperation with the St.
Swanson recently gave a talk on Compassionate Dermatology and Managing Special Needs Patients at the 2025 Diversity on Dermatology meeting in Louisville. She sat down with The Dermatology Digest to share some of the main takeaways from her presentation to help colleagues better understand and care for these patients.
DEBRA Research GmbH, a non-profit organization focused on advancing research, advocacy, and support for those affected by Epidermolysis Bullosa (EB), and LEO Pharma are partnering to accelerate the development of new therapies for EB. There are currently no approved treatment options for EB. Together, we can do so much more.
Like most skin conditions, acne doesn’t have just one cause or one treatment that will work–it can be complicated. We also touched on the importance of an integrative approach that includes diet, lifestyle, and mindset, alongside topical treatments. 00:11:17] Teenage acne treatment approaches. [00:12:55]
The National Rosacea Societys updated Rosacea Treatment Algorithms provide a comprehensive summary of therapeutic options for each phenotype of rosacea. The post Now Available: National Rosacea Societys Updated Rosacea Treatment Algorithms appeared first on The Dermatology Digest.
The field of dermatology has certainly taken advantage of these innovative tools for laser dermatologytreatments. Dermatology Partners Tyler, “Lasers are used to improve skin health and appearance in a variety of ways. In this blog, Dr. Holman talks about post laser treatment skincare to maximize your results.
2015) 'Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma', Journal of Clinical and Aesthetic Dermatology , 8(4), pp. Gendler Dermatology (2022) 'Menopause, Topical Estrogen, and Skin Health'. 2019) 'Estrogen-deficient skin: The role of topical therapy', International Journal of Women's Dermatology , 5(2), pp.
SYM2081 inhibits inflammation-driving mast cells in mouse models and human skin samples, paving the way for new topical treatments to prevent itching, hives, and other symptoms of skin conditions driven by mast cells, finds a study published in Science Translational Medicine.
After undergoing months of treatment with traditional therapies for erythroderma, which included the steroid prednisone, anti-itch creams, and immunosuppressive drugs, the patient experienced little relief. We created a new diagnostic test to discover a previously undescribed skin disease and initiate appropriate treatment.
Michele Ramien, MD, discusses biologic therapies for pediatric dermatology, focusing on their impact on vaccines, managing side effects, and tailoring treatment.
The test result, in which patients are stratified into a Class 1 (low), Class 2A (higher) or Class 2B (highest) risk category, predicts individual metastatic risk to inform risk-appropriate management and guide decision-making regarding the use of adjuvant radiation therapy.
Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Restem’s umbilical cord outer lining stem cells (ULSCs) program for the treatment of dermatomyositis (DM) and polymyositis (PM). The estimated incidence of PM/DM is approximately 5 to 22 cases per 100,000 individuals. PHOTO CREDIT: DermNet The post U.S.
Jenni Nagle, L+A CO-Founder had a CO2 laser treatment and kept an eight day diary of her recovery process! For estheticians and skincare professionals, addressing pigmentation involves understanding and applying a multimodality treatment approach, which combines various techniques to tackle pigmentation through multiple mechanisms.
anhydrous gel is showing promise in the treatment of microcystic lymphatic malformations (microcystic LMs), according to a presentation at the 15th World Congress of Pediatric Dermatology in Buenos Aires, Argentina. Food and Drug Administration (FDA)-approved therapies for microcystic LMs. Palvella Therapeutics, Inc.
Dermatology Partners Carrollton , These small, typically harmless, growths are caused by the human papillomavirus (HPV), and while many warts go away on their own, others persist, cause discomfort, and spread. While its possible for warts to resolve without treatment, this process can take months or even years. What Are Warts?
Food and Drug Administration (FDA)-approved therapies for scarring alopecia, and existing treatments are often ineffective, which is why many patients turn to complementary and alternative therapies. For the study, researchers conducted a literature review on alopecia and complementary treatments. One case study.
Dermatology Partners Fort Worth , While rosacea is a chronic condition with no known cure, there are numerous effective treatments and strategies for managing symptoms. In this blog, Dr. Durham reviews common signs and symptoms of rosacea as well as recommending effective management and treatment options.
Researchers led by Adam Friedman , MD, Professor and Chair of Dermatology at the George Washington (GW) University School of Medicine and Health Sciences in Washington, DC, and Sapana Desai, dermatology research fellow at GW, evaluated the available data to highlight the benefits of using isotretinoin for rosacea. The bottom line?
A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Nonsteroidal treatment options for AD have rapidly expanded in recent years with the development of phosphodiesterase-4 inhibitors, biologics, and Janus kinase (JAK) inhibitors.
Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors. “The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a novel T cell immunotherapy for patients with limited treatment options.”
However, any dermatology provider who has prescribed one quickly learns of the immense barriers surrounding them. Biologics represent the pinnacle of scientific progress, engineered to precisely target conditions previously deemed untreatable.
has completed enrollment in its Phase 3 clinical trial evaluating aminolevulinic acid hydrochloride (Ameluz) with photodynamic therapy (PDT) for the treatment of mild to moderate actinic keratoses (AKs) on the extremities, neck, and trunk. They are then followed up for approximately one year after the last PDT treatment.
Food and Drug Administration (FDA) approved mirdametinib (Gomekli, SpringWorks) for the treatment of adult and pediatric patients aged two and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that are not amenable to complete resection. Gomekli is an oral, small molecule MEK inhibitor.
Many people seek treatments to help fade, flatten, or minimize these marks. While no scar treatment is universal, an experienced dermatologist can offer numerous options for scar removal and remediation. Common treatments laser therapy, microneedling, fillers, and chemical peels. They appear as shallow or deep pits.
Dermatology Partners Fairfax , Whether patients are dealing with persistent blackheads, painful cystic acne, or stubborn whiteheads, the temptation to pop or pick at acne is hard to resist. Acne extractions also make it possible for acne treatments to be more effective because they are able to penetrate into pores more easily.
Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.
first pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) trial of Xyngari, a novel, once-weekly, topical product candidate for the treatment of moderate-to-severe acne. The last patient has completed their last visit in Dermata Therapeutics, Inc.s Food and Drug Administration.
While some scars fade with time, others remain more permanent and require targeted treatment. Understanding the different types of acne scars is the first step in choosing an effective treatment plan. Delayed or improper treatment of acne increases the likelihood of developing these scars. Best Treatment Options for Each Type 1.
Stelara is a currently approved treatment for adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic arthritis, moderately to severely active Crohn’s, and moderately to severely active ulcerative colitis.
An expert discusses how treatment for alopecia areata begins with topical/intralesional therapies for limited disease and progresses to systemic options for extensive involvement or treatment resistance. Treatment decisions are guided by disease severity, patient age, comorbidities, and treatment goals.
Dermatology Partners Denver , Menopause can take a toll on skin, but there are numerous dermatologictreatments to prevent and address these issues by targeting the root causes rather than hiding changes. Alexandra Theriault of U.S. Neurotoxins have proven particularly effective on crows feet and forehead lines.
This article will highlight recently approved psoriasis therapies that will shape the 2024 treatment landscape and provide some exciting updates in the psoriasis management market this coming year and beyond.
Dermatology experts discuss the use of systemic therapy in plaque psoriasis and determining patient response to treatment, also commenting on the use of PASI scoring in the clinical setting.
Before and after images are essential in medical esthetics as they provide visual proof of treatment efficacy, helping clients see real, measurable results. They also serve as valuable tools for patient education, helping individuals set realistic expectations for their treatments. SHAPESCALE 6.
Torqur AGs topical bimiralisib, a selective pan-PI3K/mTOR inhibitor, may help clear actinic keratosis (AK) lesions, according to interim Phase 2 results presented at the American Academy of Dermatology in Orlando, FL. The post Torqur AGs Bimiralisib Gel Shows Promise in AK appeared first on The Dermatology Digest.
The Dermatology Association of Radiation Therapy (DART) is urging dermatologists and other stakeholders to oppose a proposed policy that would cancel Medicare coverage for image-guided superficial radiation therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer in seven states.
Thankfully, several non-surgical treatments can address these concerns effectively. Here, we’ll explore Emface, Ultherapy, Kybella, CoolSculpting, jawline filler, Elastiderm and Nectifirm, Exosome therapy, and other options. This treatment is used alongside other therapies for an overall enhanced appearance.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content